HSPE1 and colorectal carcinoma: Targeting various HSPs for cancer chemotherapy has recently gained attention due to their significant role in CRC progression; however, few studies have targeted HSP60 activity and its co-chaperone HSP10 for CRC treatment due to their controversial role in different cancers.